English, , 1,189kb
This report is based on an examination of some 20 roadmaps. It focuses on the process through which they were prepared, and identifies key considerations and good practices that deserve the attention of anyone contemplating the undertaking of a new roadmapping exercise.
Cette publication traite de l’importance et des implications en termes de politique des flux internationaux de ressources humaines en science et technologie (RHST). Elle vise à élargir la compréhension de la mobilité des RHST, en particulier des scientifiques, ingénieurs et chercheurs.
This paper presents different indicators using existing data on R&D investments, innovation survey data, patent data and data on licensing, illustrating the increasing importance and the different characteristics of open innovation across companies, industries and countries.
English, , 80kb
Two-page brief presenting the OECD Innovation Strategy. Complete information on the project is available at www.oecd.org/innovation/strategy.
This working paper reflects an initial analysis using a pioneering new OECD database. It is among the first systematic attempts to analyse comparatively the distribution of innovative activity across OECD regions with a set of homogenous measures.
The impact of biotechnologies on medical research is intensifying. Because of new highly performing technologies, we are better able to understand and explore disease and drug mechanisms, which in turn could lead to major changes in the approach of patient care.
The STI Outlook uses the latest available data and indicators to review key trends in science, technology and innovation in OECD countries and a number of major non-member economies.
Les Perspectives de la science, de la technologie et de l’industrie de l’OCDE offre un tour d’horizon complet des tendances clés de la politique de la science, de la technologie et de l’innovation en passant en revue les évolutions récentes des politiques publiques dans les pays de l’OCDE.
In November 2007 the Working Party on Biotechnology established a new Task Force on Biomedicine and Health Innovation. The Task Force was asked to develop a Synthesis Report of the main policy messages that emerged from OECD work related to innovation and health.
This publication assesses the current status of Hungary’s innovation system and policies, and identifies where and how the government should focus its efforts to improve the country's innovation capabilities.